news on tirzepatide The US-FDA has approved for chronic weight management in adults with Obesity - Tirzepatide cuts risk of diabetes

What about interactions with other medications that work for cardiovascular issues, like blood thinners

Improved glycemic control also reduces glucose-mediated nerve damage, which could lessen neuropathic symptoms over time

Never adjust or initiate any medication licensed or otherwise without professional guidance

This medicine is not an insulin and should not be used if: you have type 1 diabetes a condition where your body does not produce any insulin 2 you develop diabetic ketoacidosis a complication of diabetes with high blood sugar, breathing difficulty, confusion, excessive thirst, a sweet smell to the breath or a sweet or metallic taste in the mouth

In the STEP trials, participants who started semaglutide lost an average of 15 to 22% of their baseline body weight over 68 weeks